(Q33501155)

27 July 2017

Epidemic hemolytic-uremic syndrome in children (English)

1 reference

hemolytic-uremic syndrome

27 July 2017

1 reference

1 reference

Repetto HA

1

1 reference

PubMed ID

9407523

27 July 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

6

1 reference

27 July 2017

1708-1719

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.508

27 July 2017

0 references

cites work

The Hemolytic-Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The Hemolytic-Uremic Syndrome Is a Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

HUS and TTP: variable expression of a single entity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Acute renal failure in infancy and childhood. Clinical course and treatment of 41 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

THE HEMOLYTIC-UREMIC SYNDROME.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Serological identification of Escherichia coli 0157 as cause of haemolytic uraemic syndrome in Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Heparin therapy in the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The use of intravenous gammaglobulin in the treatment of typical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic-uremic syndrome with shigellosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Shiga bacillus dysentery complicated by bacteremia and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Haemolytic uraemic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Recovery from prolonged coma in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Cadaveric renal transplantation in children under 5 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Pancreatic islet cell necrosis: association with hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Exocrine and endocrine pancreatic insufficiency and calcinosis after hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Outcome and prognostic determinants in the hemolytic uremic syndrome of children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Renal functional reserve in children with a previous episode of haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemodynamically mediated glomerular injury and the progressive nature of kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemodynamic theory of progressive renal disease: a 10-year update in brief review

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Renal functional reserve compared in haemolytic uraemic syndrome and single kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Association between severity of gastrointestinal prodrome and long-term prognosis in classic hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

An approach to protein restriction in children with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Recurrent thrombotic microangiopathy in a renal allograft. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Renal transplantation and immunological abnormalities in thrombotic microangiopathy of adults: report of 5 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Renal transplantation in patients with classical haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic uremic syndrome in renal allografted patients treated with cyclosporin.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The haemolytic uraemic syndrome and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Neutrophil elastases and haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Chemotherapy-induced hemolytic uremic syndrome: description of a potential animal model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Hemolytic uremic syndrome: MR findings of CNS complications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Fewer nephrons at birth: a missing link in the etiology of essential hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Escherichia coli O157:H7 and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Haemolytic uraemic syndrome and unpasteurized milk

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.508

7 January 2021

Identifiers

DOI

10.1038/KI.1997.508

1 reference

PubMed ID

9407523

Dimensions Publication ID

27 July 2017

0 references

1 reference

PubMed ID

9407523